EPAM's AI Transition: Replacement Revenue and Strong Buybacks

What happened

EPAM Systems faces a challenging transition as AI disrupts its traditional software services, but the company's adaptability and capital return potential remain undervalued, according to a recent Seeking Alpha analysis. AI-related revenue reached 11% of Q2 2026 sales, though much of this merely replaces legacy work, limiting near-term growth acceleration. Management is aggressively repurchasing shares, supported by a strong net cash position and a compelling valuation (EV/EBITDA 7x, P/CF 11x). The existing DeepValue master report, based on data through Q2 2025, already highlighted EPAM's scaled engineering franchise, net cash of ~$1.3 billion, and ongoing buybacks as key support. While the new data confirms AI is growing, the replacement nature suggests a more gradual margin and growth inflection than originally hoped, but the low valuation and capital returns still provide downside protection.

Implication

Given the replacement nature of much AI revenue, EPAM's near-term growth may be more muted than bulls anticipate, yet the deep discount (EV/EBITDA 7x) and aggressive buybacks offer a margin of safety. The stock's downside appears limited by its net cash position and cash generation, while any operational improvements from cost optimization and AI production ramp could provide upside. However, monitoring is essential for signs that AI revenue is generating incremental demand rather than cannibalizing legacy work. For value-oriented investors with a patient horizon, EPAM presents an asymmetric opportunity; for growth investors, the lack of clear acceleration is a concern. Overall, maintaining a BUY stance but with reduced conviction on near-term growth catalysts is prudent.

Thesis delta

The original BUY thesis was based on AI modernization from pilots to production and margin rebuild via cost optimization. The new data indicating that 11% of Q2 2026 revenue is AI-related but mostly replacement suggests the AI transition is more defensive than offensive, limiting incremental growth. Consequently, while the valuation and buyback support remain intact, the growth component of the thesis is weakened, shifting the investment case more toward a value play with modest upside rather than a high-growth re-rating story. The stance remains BUY but with lower expected growth trajectory.